On the recordApril 6, 2014
This lack of predictability in the timing of DEA scheduling decisions leads to unnecessary uncertainty in the drug development process and needless delays in patients' access to new therapies.
Source
congress.govEditor's note · Context
Highlighting issues with DEA scheduling affecting drug development.
Share
More from Joe Pitts
Jul 6, 2016
I thank Mr. Murphy for his leadership and his persistence in getting this historic legislation to the floor. When a person struggles with mental illness, he or she may lose her job, her friends, even her family, which can make the mental…
Sep 13, 2016
Because of the Affordable Care Act, now over 20 million people in this country who were in that situation literally overnight are no longer in that situation.
Sep 7, 2016
H.R. 1717, the Sober Truth on Preventing Underage Drinking Reauthorization Act or the STOP Act, sponsored by Rep. Roybal-Allard (CA) provides for programs and activities to prevent underage drinking.
Sep 13, 2016
Administrator Slavitt, CMS announced that APTC and CSR subsidies would be ended for 2016 enrollees who received APTCs in 2014 but did not reconcile these payments on their federal taxes.
Other voices in this conversation
